AI Pre-Consultation Summary (with Research)

Your doctor walks into every consult already briefed — history, ICD-10, drug suggestions, all cited from real guidelines.

Start free trial Book a demo

Live demo · sample data

Pre-Consultation Summary

Sunita Patel · 54 · F · generated 2h before the visit

High confidence

Type 2 DiabetesHypertensionDyslipidemia

For doctor only — not shared with patient

Download Preview Print Rx Regenerate

Clinical bottom-line

Worsening glycemic control with new visual symptoms in a known hypertensive — intensify therapy and screen for retinopathy.

Clinical summary

54-year-old female, known hypertensive, presents with 3 weeks of increased thirst, polyuria, fatigue and new blurred vision. BP elevated at 144/88, BMI 29.8. Picture is consistent with newly uncovered Type 2 Diabetes with possible early retinopathy; dyslipidemia and renal function to be assessed. Plan: confirm with HbA1c + fasting glucose, screen the fundus, and start first-line therapy.

Vitals

BP 144/88

PR 86

RR 18

Temp 98.4°F

SpO₂ 97%

Wt 84 kg

Ht 168 cm

BMI 29.8

Suspected conditions

E11.9· Type 2 diabetesH53.8· Visual disturbanceI10· Hypertension

Recommended tests

HbA1c · Fasting glucose · Fundus examination · Lipid profile · Serum creatinine · TSH

Medicines

Medicine	Mor	Aft	Ngt	Instructions
Metformin 500mg				After food
Telmisartan 40mg				Before breakfast
Atorvastatin 10mg				At bedtime

Treatment Plan · clinical management

Type 2 DiabetesE11.9

Start Metformin 500mg BD; reinforce lifestyle changes.

Target: HbA1c < 7% Recheck HbA1c in 3 months

HypertensionI10

Telmisartan 40mg OD; advise home BP monitoring.

Target: BP < 130/80 Review in 4 weeks

DyslipidemiaE78.5

Atorvastatin 10mg at bedtime.

Target: LDL < 100 mg/dL Repeat lipid profile in 6 weeks

Follow-up: review in 4 weeks with HbA1c, fasting glucose, lipid profile & serum creatinine. Referral: Ophthalmology for dilated fundus / retinopathy screening.

Observed: Polyuria, polydipsia & fatigue for 3 weeks in a known hypertensive

Interpretation: High pre-test probability of Type 2 Diabetes

ICMR T2DM 2018

Observed: New-onset blurred vision

Interpretation: Screen for diabetic retinopathy → fundus exam

ICMR-NPCDCS

Observed: Hypertensive diabetic, eGFR adequate

Interpretation: Prefer an ARB for renal protection

NICE NG28

AI-generated reference from ICMR / WHO / BNF for doctor review. Not a prescription. Not a substitute for clinical judgment.

Before the patient sits down, InZob prepares a clinical brief: chief complaint, relevant history, suspected conditions with ICD-10 codes, recommended investigations, and drug suggestions — each with a confidence score and a reasoning chain. Every recommendation is grounded in real literature (NICE, WHO, ICMR, PubMed) so the doctor can trust and verify in seconds.

Walk in informed

Full history + suspected conditions ready before the patient enters.

Cited from guidelines

Every suggestion links to NICE / WHO / ICMR / PubMed evidence.

Transparent reasoning

See exactly why the AI suggested each condition and drug.

How it works

Patient history & documents are gathered

AI retrieves matching clinical evidence (RAG)

Generates summary with ICD-10 + drug suggestions

Doctor reviews the reasoning chain and confirms

Continue the journey

See how this connects to the rest of the platform.

Treatment Personalization AI

See what actually worked for similar patients

Drug Safety & Dosing Intelligence

Every drug the doctor picks is safety-checked

See InZob work for your team

Start free, or explore every feature in the platform.

Start free trial View all features